--ARCHIVE_PAGE_LINK--
 
 
 
 
 
MAY 26, 2020
 
 
 
Roundtable
 
 
Quick Links
 
 
 
Epstein Becker & Green, P.C.

Robinson & Cole LLP

Davis Kuelthau

Mintz

Stark & Stark



 
Knox Law Services
 
 
Healthcare Legal News
Coronavirus Edition
With the growing spread of the Coronavirus (COVID-19) in recent weeks, many government agencies have taken steps to mitigate the impact on individuals and businesses. At The National Law Review, we're dedicated to making all of the latest legal news around this global health crisis available to tax professionals.  You can access Coronavirus-related updates on our Coronavirus News page updated hourly. 
 
 
 
 
The Coronavirus (COVID-19) pandemic poses an acute health risk to the population. One key to successfully combating COVID-19 lies in clinical research. Currently, almost all major research-based pharmaceutical companies, many other pharmaceutical and biotech companies, and research institutions worldwide are engaged in a race to develop effective drugs and vaccines against COVID-19 in preclinical and clinical research. In the field of therapeutic drugs, hopes are pinned not only on the development of new drugs, but also on the repurposing of drugs developed for other infectious diseases that are currently undergoing clinical trials or are already approved.  More on Fast Track Vaccine Approval Here >
 
 
 
Ogletree Deakins  Law Firm  Logo
Employees have filed thousands of complaints with the federal Occupational Safety and Health Administration (OSHA) against healthcare and other employers over alleged safety lapses related to COVID-19. Common concerns cited by employees include a general fear of contracting the virus; a fear of bringing the virus home to family members; the lack of personal protective equipment (PPE) and other safety measures; the inability to distance while working; staffing shortages; and being disciplined for raising concerns or refusing to work.  More on Employee Refusal to work in Healthcare Here >
 
 
 
Robinson Cole Law Firm
The period of reduced economic activity in the United States due to the novel coronavirus pandemic has resulted in fewer in-office health care visits and procedures and, therefore, reduced claims costs for health insurers. This situation will likely continue for some time beyond the official reopenings of states and municipalities.  Even before the pandemic, insurers in the individual market reported an estimated record-high $2 billion in Affordable Care Act-required Medical Loss Ratio (MLR) rebates this year based on preliminary financial performance in 2017, 2018 and 2019. According to the Kaiser Family Foundation, the estimated average loss ratios of insurers in the individual market for these years were 82% in 2017, 70% in 2018 and 79% in 2019.  More on Premium Insurance Discounts Here >
 
 
 
Foley Lardner Law Firm
Since President Trump declared a national emergency concerning the Novel Coronavirus Disease (COVID-19) outbreak on March 13, 2020, the health care industry has witnessed increased focus by investors on sectors closely tied to combating the disease, assisting people with coping with COVID-19 and delivering health care while abiding by social distancing measures. This article discusses three areas in the industry that are still attracting investment activity amid the COVID-19 pandemic.  More on Health Care Investment Here >
 
 
 
 
The National Law Review
In house attorneys looking for a better way to organize, vet and easily retrieve legal news created the National Law Review on-line edition.

Around the clock, the National Law Review's editors screen and classify breaking news and analysis authored by recognized legal professionals and our own journalists.

There is no log in to access the database and new articles are added hourly.
 
 
 
 
Please let other interested professionals know about this valuable and free resource!

If you know someone interested in publishing with the National Law Review, kindly contact us at:
   
The National Law Review
National Law Forum, LLC
Jennifer Schaller, Esq.
 
 
 
 
NLR Publication Areas
 
 
 
 
 
 
 
 
 
 
 
 
​​​​
 
 
 
The National Law Review
 708-357-3317 | jschaller@natlawreview.com | www.natlawreview.com
4700 Gilbert Avenue Suite #47 #230
Western Springs, IL 60558